The Effects of Neoadjuvant Metformin on Tumour Cell Proliferation and Tumour Progression in Pancreatic Ductal Adenocarcinoma
Condition(s):Resectable Pancreatic Ductal AdenocarcinomaLast Updated:January 18, 2018Unknown status
Hide Studies Not Open or Pending
Condition(s):Resectable Pancreatic Ductal AdenocarcinomaLast Updated:January 18, 2018Unknown status
Condition(s):Polycystic Ovary Syndrome; Metformin; Immune FunctionLast Updated:March 22, 2024Recruiting
Condition(s):Fragile X SyndromeLast Updated:February 4, 2021Completed
Condition(s):PsA (Psoriatic Arthritis)Last Updated:February 7, 2024Recruiting
Condition(s):Age-Related Macular Degeneration; Macular Degeneration, Age-Related; Dry Macular Degeneration; Geographic AtrophyLast Updated:June 9, 2023Completed
Condition(s):Glioma; Cholangiocarcinoma; ChondrosarcomaLast Updated:January 9, 2020Completed
Condition(s):Preeclampsia; Preeclampsia Severe; High Risk Pregnancy; EclampsiaLast Updated:March 29, 2022Unknown status
Condition(s):Chronic Hepatitis C InfectionLast Updated:November 23, 2016Completed
Condition(s):Diabetes Mellitus, Type 2; Metformin Adverse ReactionLast Updated:December 5, 2017Completed
Condition(s):VitiligoLast Updated:June 2, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.